Irvine-based California Stem Cells said Friday morning that the firm has secured a Series A financing round, from undisclosed private investors. Amount of the investment was not disclosed. The firm said that it will use the funding to expand its laboratory and manfacturing facilities. California Stem Cells said it is focused on the manufacturing of high-purity human stem cells, for use in pre-clinical development of treatments for cardiac and central nervous system disorders. More information »